Attached files

file filename
8-K - FORM 8-K - Benefytt Technologies, Inc.d894268d8k.htm

Exhibit 99.1

Health Insurance Innovations, Inc. Reports Fourth Quarter and Fiscal 2014 Financial and Operating Results

Record 2014 Revenue of $89 million, Up 57% from 2013

Q4 2014 Adjusted Earnings per Share of $0.12

Full Year 2014 Adjusted Earnings per Share of $0.38

TAMPA, Fla., March 18, 2015 — Health Insurance Innovations, Inc. (NASDAQ:HIIQ) (“HII” or “Company”) is a leading developer, distributor and virtual administrator of affordable, cloud-based individual health insurance plans and ancillary products. HealthPocket, Inc., a subsidiary of HII (“HealthPocket”), is the most comprehensive consumer comparison shopping website for health insurance plans. HII today reported consolidated financial and operating results for the fourth quarter and full fiscal year ended December 31, 2014. The Company will host a conference call and webcast at 5:00 p.m. EDT, Wednesday, March 18, 2015.

Fourth Quarter 2014 Consolidated Financial Highlights

 

    Record revenue of $26.5 million, an increase of 67.7% over $15.8 million in the fourth quarter of 2013. This was HII’s twelfth straight quarter of sequential quarterly revenue growth.

 

    Total collections from customers, which our industry refers to as premium equivalents, was $45.7 million, representing 65.0% growth from $27.7 million in the fourth quarter of 2013. See the Reconciliation of Premium Equivalents to Revenues and Adjusted Gross Margin in this press release.

 

    Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) was $2.8 million for the fourth quarter of 2014, up 55% compared to $1.8 million for the same period in 2013. See Reconciliation of Net Income (Loss) to EBITDA and Adjusted EBITDA included within this press release.

 

    Net income per diluted share for the fourth quarter of 2014 was $0.01 compared to net income of $0.06 per diluted share in the fourth quarter of 2013.

 

    Adjusted EPS, also referred to as Net Income per Share was $0.12 for the fourth quarter of 2014, up 50% compared to $0.08 in the fourth quarter of 2013. See Reconciliation of Adjusted EBITDA to Adjusted Net Income per Share within this press release.

 

    Cash generated from operations during 2014 was $2.0 million. At December 31, 2014, the Company had $14.7 million in cash and short-term investments and no long-term debt.

“We were pleased that we exceeded our annual revenue guidance with a record revenue quarter and delivered strong profit growth as well. We also continued to make good progress on our strategic priorities and positioning the business for long term sustainable growth,” said Michael Kosloske, HII’s Chief Executive Officer and President.

Full Year 2014 Consolidated Financial Highlights

 

    Record annual revenues of $88.8 million, representing a 56.9% increase from fiscal year 2013, exceeding external guidance of 50% growth vs. prior year.

 

    Record premium equivalents of $156.0 million, representing a 56.0% increase from fiscal year 2013.


    Adjusted gross margin of $41.7 million, representing 79.7% growth from $23.2 million in 2013. For the full year, the ratio of adjusted gross margin to premium equivalents was 26.8% in 2014, compared to 23.2% for 2013.

 

    Adjusted EBITDA of $8.1 million, up 37% compared to $5.9 million in 2013.

 

    Net income of $0.4 million, compared to net loss of $8.4 million for the fiscal year ended 2013.

 

    Cash generated by operations during the year was $2.0 million and the Company had cash and short term investments totaling $14.7 million as of the end of fiscal year 2014.

 

    Record policies in force as of December 31, 2014, totaled 106,243, a 44.2% increase from 73,686 at December 31, 2013.

 

    Net loss per diluted share for the year ended 2014 was $0.06 compared to net loss of $0.70 per diluted share in the fiscal year ended 2013.

 

    Adjusted EPS or Net Income per Share was $0.38 for the year ended in 2014, up 40.7% compared to $0.27 for the fiscal year ended in 2013.

HealthPocket, Inc. Update

Headquartered in Mountain View, CA, HealthPocket was acquired by HII in July 2014. HealthPocket provides consumers with access to its leading health insurance information, search and comparison technology through its website, www.healthpocket.com. This free website allows consumers to easily compare and rank all health insurance plans available.

HealthPocket’s key metrics for the fourth quarter were as follows:

 

  Record Health Plan Queries of 930,000, representing 74% growth in the number of queries over the third quarter of 2014. A Health Plan Query is registered for each consumer that receives a health insurance quote on www.healthpocket.com.

 

  Record Client Referrals of 256,000, representing 144% growth over the number of referrals in the third quarter of 2014. Client Referrals are targeted phone and online referrals sold by HealthPocket to fulfillment partners or handled in-house by one of HII’s owned call centers.

 

  Referral Mix of 73%. Referral Mix is the percentage of Client Referrals that are Obamacare, short term medical and ancillary product category referrals, with the remainder being Medicare referrals.

“We were very pleased with the strong sequential growth in our two key growth metrics, health plan queries and client referrals. Client referrals more than doubled from the third to the fourth quarter and we achieved our goal to fulfill more than 50% of our targeted referrals through HII and its strategic distribution partners,” said Bruce Telkamp, CEO of HealthPocket, Inc.


Fourth Quarter and Annual 2014 Financial Discussion

Comparability between the years ended December 31, 2014 and 2013 is affected by acquisitions during those years. For the year ended December 31, 2014, we operated as two operating segments: 1) Insurance Plan Development and Distribution (“IPD”) and 2) HealthPocket (“HP”). For the year ended December 31, 2013, we operated as a single operating segment: IPD. The IPD segment comprises our business activities in designing, implementing and administering STM and other products and the distribution of those products to consumers via our distribution network or online purchases. The HP segment comprises the business activities of HealthPocket, including the development of HealthPocket.com and the generation of referral-based and other revenues. The financial discussion below is made at a consolidated level. Refer to the table that shows the financial results of our operating segments for the year ended December 31, 2014 in this press release.

Fourth quarter revenues of $26.5 million and premium equivalents of $45.7 million increased by 67.7% and 65.0%, respectively, over the same metrics for the fourth quarter of 2013. For the full year, 2014 revenues increased 56.9% to $88.8 million compared to 2013. Premium equivalents increased 56.0% to $156.0 million for 2014, compared to $100.0 million in 2013. The increases were primarily due to the increase in the number of policies in force as a result of our continuing expansion of our distribution network. A reconciliation of premium equivalents to revenues for the three months and annual periods ended December 30, 2014, and 2013, is in the financial supplement included in this press release. By policy type, the 2014 fourth quarter mix of revenues was as follows: 55% short-term medical, 15% hospital indemnity, and 30% ancillary products for the fourth quarter; and 59% short-term medical, 19% hospital indemnity, and 22% ancillary products for all of 2014.

Adjusted gross margin, which is calculated starting with revenues and then adjusted for third party commissions, and credit card and ACH fees, increased to $11.9 million or 26.0% of premium equivalents for the fourth quarter of 2013, compared to $7.7 million of adjusted gross margin and 27.8% of premium equivalents in the same period in 2013. For the full year, adjusted gross margin was $41.7 million or 26.8% of premium equivalents, compared to $23.2 million or 23.2% of premium equivalents in 2013. A reconciliation of premium equivalents to revenues and adjusted gross margin for the three months and years ended December 31, 2014 and 2013 is included within this press release.

Selling, general and administrative (“SG&A”) expenses were $10.0 million in the fourth quarter, compared to $7.9 million in 2013. For the year, SG&A expenses were $37.5 million, an increase of $13.5 million from 2013. For both the quarter and the year, the increase in G&A expense was primarily driven by transaction expenses, the impact of acquisitions and investments in growth initiatives to drive sustainable growth in 2015 and beyond.


During the fourth quarter of 2014, the Company had pre-tax income of $0.8 million in comparison to pre-tax loss of $1.0 million in the fourth quarter of 2013. For the full year, the Company reported pre-tax income of $0.5 million in comparison to a pre-tax loss of $8.4 million in 2013. The primary drivers of 2014 income were increase in revenues and relative decrease in incremental costs.

EBITDA (earnings before interest, taxes, depreciation and amortization) was $2.9 million for 2014 compared to $(7.1) million in 2013. Adjusted EBITDA is calculated starting with EBITDA, which is then further adjusted for items that are not part of regular operating activities, including acquisition costs, contract termination costs, and other non-cash items such as stock-based compensation. Adjusted EBITDA was $8.1 million for 2014, compared to $5.9 million in 2013. A reconciliation of net (loss) income to EBITDA and Adjusted EBITDA for 2014 and 2013 is included within this press release.

For the year ended 2014, cash generated in operations was $2.0 million compared to cash used from operations of $1.2 million in 2013. Cash and short term investments totaled $13.9 million at the end of Q4 and the Company has no debt. In December 2014, HII entered into a three year revolving line of credit for $15 million with SunTrust Bank, N.A. The establishment of this credit facility is consistent with the Company’s strategy of ensuring that the company has more than ample liquidity to fund operations.

2015 Outlook

HII will be providing specific guidance for 2015 full year results as part of its first quarter earnings call in early May, consistent with the timing of full year guidance provided last year and also due in part to rapidly changing market conditions and health care policy decisions.

Conference Call and Webcast

HII will host a conference call and webcast to discuss these results on Wednesday, March 18, 2015 at 5:00 p.m. Eastern Time. The toll free dial-in number is (877) 312-8797; the toll number is (678) 825-8236; the conference ID is 74267247. A webcast of the conference call may be accessed in the Investor Relations section of HII’s website at http://investor.hiiquote.com/events.cfm. The webcast will be archived for 30 days. Copies of the earnings release and other financial information about HII may also be accessed in the Investor Relations section of HII’s website at www.hiiquote.com. Copies of this press release and other financial information about HII may also be accessed in the Investor Relations section of HII’s website at www.hiiquote.com. The Company regularly posts or otherwise makes available information within the Investor Relations section of HII’s website that may be important to investors.

About Health Insurance Innovations, Inc.

Health Insurance Innovations, Inc. (“HII”) develops affordable, high-quality health insurance products through partnerships with best-in-class insurance carriers, distributed through licensed insurance agents as plan configurations customized for the individual consumer. These transactions take place via the industry’s first virtual administrator, an entirely cloud-based proprietary process —Quote-Buy-Print— providing proof-of-coverage to insured in minutes rather than weeks. HII is a data-driven digital business informed by its consumer division.


HII’s consumer division includes HealthPocket.com’s Research & Data business, the largest repository (of any kind) of health insurance information. Additional information about HII can be found at www.hiiquote.com.

About HealthPocket.com

HealthPocket.com is a free website that compares and ranks all health insurance plans available to an individual, family, or small business to allow consumers to make their best health plan decisions and reduce their out of pocket costs. HealthPocket uses only objective data from government, non-profit, and private sources that carry no conditions that might restrict the site from serving as an unbiased resource. HealthPocket, based in Mountain View, California, is an independently-managed subsidiary of HII. Additional information can be found at www.healthpocket.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements other than historical fact, and may include statements relating to goals, plans and projections regarding new markets, products, services, growth strategies, anticipated trends in our business and anticipated changes and developments in the United States health insurance system and laws. Forward-looking statements are based on HII’s current assumptions, expectations and belief are generally identifiable by use of words “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” or similar expressions and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements. These risks and uncertainties include, among other things, our ability to maintain relationships and develop new relationships with health insurance carriers and distributors, our ability to retain our members, the demand for our products, the amount of commissions paid to us or changes in health insurance plan pricing practices, our ability to integrate our acquisitions (including our July 2014 acquisition of HealthPocket, Inc.), competition, changes and developments in the United States health insurance system and laws, and HII’s ability to adapt to them, the ability to maintain and enhance our name recognition, difficulties arising from acquisitions or other strategic transactions, and our ability to build the necessary infrastructure and processes to maintain effective controls over financial reporting. These and other risk factors that could cause actual results to differ materially from those expressed or implied in our forward-looking statements are discussed in HII’s Annual Report on Form 10-K for the year ended December 31, 2013 and subsequent Quarterly Reports on Form 10-Q, all as filed with the Securities and Exchange Commission as well as other documents that may be filed by HII from time to time with the Securities and Exchange Commission. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. You should not rely on any forward-looking statement as representing our views in the future. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.


HEALTH INSURANCE INNOVATIONS, INC.

(Prior to February 13, 2013 Health Plan Intermediaries, LLC and Subsidiaries)

Consolidated Balance Sheets

(Unaudited)

($ in thousands, except share amounts)

 

     December 31,  
     2014     2013  

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 14,256      $ 17,054   

Cash held on behalf of others

     7,642        4,591   

Investment proceeds receivable

     —          15,000   

Short-term investments

     461        6,877   

Accounts receivable, prepaid expenses and other current assets

     2,332        963   

Advanced commissions

     5,973        2,596   

Income taxes receivable

     12        395   
  

 

 

   

 

 

 

Total current assets

  30,676      47,476   

Property and equipment, net

  526      389   

Goodwill

  41,076      18,014   

Intangible assets, net

  13,565      5,281   

Other assets

  329      489   
  

 

 

   

 

 

 

Total assets

$ 86,172    $ 71,649   
  

 

 

   

 

 

 

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable and accrued expenses

$ 11,397    $ 7,074   

Current portion of contingent consideration

  2,647      1,945   

Deferred revenue

  64      882   

Deferred tax liability

  13      —     

Due to member

  229      916   

Other current liabilities

  189      187   
  

 

 

   

 

 

 

Total current liabilities

  14,539      11,004   

Contingent acquisition consideration

  1,753      1,931   

Deferred tax liability

  2,287      —     

Due to member

  387      423   

Other liabilities

  494      514   
  

 

 

   

 

 

 

Total liabilities

  19,460      13,872   

Commitments and contingencies

Stockholders’ equity:

Class A common stock (par value $0.001 per share, 100,000,000 shares authorized; 7,900,085 and 5,309,594 shares issued, respectively; and, 7,852,941 and 5,179,713 outstanding, respectively)

  8      5   

Class B common stock (par value $0.001 per share, 20,000,000 shares authorized; 6,841,667 and 8,566,667 shares issued and outstanding, respectively)

  7      9   

Preferred stock (par value $0.001 per share, 5,000,000 shares authorized; no shares issued and outstanding)

  —        —     

Additional paid-in capital

  42,647      28,787   

Treasury stock, at cost (47,144 and 129,881 shares, respectively)

  (347   (1,563

Accumulated deficit

  (3,694   (3,355
  

 

 

   

 

 

 

Total Health Insurance Innovations, Inc. stockholders’ equity

  38,621      23,883   

Noncontrolling interests

  28,091      33,894   
  

 

 

   

 

 

 

Total stockholders’ equity

  66,712      57,777   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

$ 86,172    $ 71,649   
  

 

 

   

 

 

 


Health Insurance Innovations, Inc.

(Prior to February 13, 2013 Health Plan Intermediaries, LLC and Subsidiaries)

Consolidated Statements of Operations

(Unaudited)

($ in thousands, except share and per share data)

 

     Three Months Ended
December 31,
    Year Ended December 31,  
     2014      2013     2014     2013  

Revenues (premium equivalents of $45,664 and $27,746 for the three months ended December 31, 2014 ad 2013, respectively, and $156,039 and $100,002 for the year ended December 31, 2014 and 2013, respectively)

   $ 26,530       $ 15,821      $ 88,758      $ 56,639   

Cost of revenues

     1,994         —          2,391        —     
  

 

 

    

 

 

   

 

 

   

 

 

 

Gross margin

  24,536      15,821      86,367      56,639   
  

 

 

    

 

 

   

 

 

   

 

 

 

Operating expenses:

Third-party commissions

  12,183      7,806      42,760      32,244   

Credit cards and ACH fees

  496      312      1,863      1,173   

Contract termination

  —        —        —        5,500   

Selling, general and administrative

  10,026      7,949      37,504      23,959   

Depreciation and amortization

  644      400      2,367      1,313   
  

 

 

    

 

 

   

 

 

   

 

 

 

Total operating expenses

  23,349      16,467      84,494      64,189   
  

 

 

    

 

 

   

 

 

   

 

 

 

Income (loss) from operations

  1,187      (646   1,873      (7,550

Other expense (income):

Interest expense (income)

  4      (13   (13   1   

Fair value adjustment of contingent consideration

  213      389      1,103      453   

Other expense

  203      24      270      397   
  

 

 

    

 

 

   

 

 

   

 

 

 

Net income (loss) before income taxes

  767      (1,046   513      (8,401

Provision (benefit) for income taxes

  295      (454   90      18   
  

 

 

    

 

 

   

 

 

   

 

 

 

Net income (loss)

  472      (592   423      (8,419

Net income (loss) attributable to noncontrolling interests

  398      (921   762      (5,064
  

 

 

    

 

 

   

 

 

   

 

 

 

Net income (loss) attributable to Health Insurance Innovations, Inc.

$ 74    $ 329    $ (339 $ (3,355
  

 

 

    

 

 

   

 

 

   

 

 

 

Per share data:

Net income (loss) per share attributable to Health Insurance Innovations, Inc.

Basic

$ 0.01    $ 0.07    $ (0.06 $ (0.70
  

 

 

    

 

 

   

 

 

   

 

 

 

Diluted

$ 0.01    $ 0.06    $ (0.06 $ (0.70
  

 

 

    

 

 

   

 

 

   

 

 

 

Weighted average Class A shares outstanding

Basic

  7,597,868      4,925,541      6,057,976      4,813,222   

Diluted

  7,628,496      5,071,242      6,057,976      4,813,222   


Health Insurance Innovations, Inc.

(Prior to February 13, 2013 Health Plan Intermediaries, LLC and Subsidiaries)

Segment Operating Results

(Unaudited)

($ in thousands)

For the year ended December 31, 2014, we operated as two operating segments: 1) Insurance Plan Development and Distribution (“IPD”), and 2) HealthPocket. For the year ended December 31, 2013, we operated as a single operating segment. The following table shows the financial results of our operating segments for the year ended December 31, 2014.

 

     Insurance Plan
Development
and
Distribution
     HP      Inter-Segment
Eliminations
     Consolidated
Total
 

Revenues

   $ 85,960       $ 3,258       $ (460    $ 88,758   

Gross margin

     85,960         867         (460      86,367   

Other operating expenses

     80,720         1,867         (460      82,127   

Depreciation and amortization

     1,730         637         —           2,367   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total operating expenses

  82,450      2,504      (460   84,494   

Other expense

  1,354      6      —        1,360   

Net income (loss) before income taxes

  2,156      (1,643   —        513   

Provision (benefit) for income taxes

  757      (667   —        90   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income (loss)

$ 1,399    $ (976 $ —      $ 423   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets as of December 31, 2014

$ 55,041    $ 31,723    $ (592 $ 86,172   
  

 

 

    

 

 

    

 

 

    

 

 

 


Reconciliation of Net Income (Loss) to EBITDA and Adjusted EBITDA

For the Three Months and Year Ended December 31, 2014 and 2013

(unaudited)

(in thousands)

 

     Three months ended
December 31,
    Year Ended December 31,  
     2014     2013     2014     2013  

Net income (loss)

   $ 472      $ (592   $ 423      $ (8,419

Interest expense (income)

     4        (13     (13     1   

Depreciation and amortization

     644        400        2,367        1,313   

Provision for income taxes

     295        (454     90        18   
  

 

 

   

 

 

   

 

 

   

 

 

 

EBITDA (1)

  1,415      (659   2,867      (7,087
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-cash stock based compensation

  846      2,020      2,454      6,296   

Fair value adjustment to contingent consideration

  165      389      1,103      453   

Transaction costs

  23      —        776      301   

Tax receivable agreement liability adjustment

  (194   49      —        423   

Other non-recurring charges

  500      —        863      —     

Contract termination expense

  —        —        —        5,500   
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA (2)

$ 2,755    $ 1,799    $ 8,063    $ 5,886   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) EBITDA is defined as net income before interest expense, income taxes and depreciation and amortization. EBITDA does not represent, and should not be considered as, an alternative to net income or cash flows from operations, each as determined in accordance with U.S. generally accepted accounting principles, or U.S. GAAP. We have presented EBITDA because we consider it an important supplemental measure of our performance and believe that it is frequently used by analysts, investors and other interest parties in the evaluation of companies. Other companies may calculate EBITDA differently than we do. EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under U.S. GAAP.
(2) To calculate adjusted EBITDA, we calculate EBITDA, which is then further adjusted for items that are not part of regular operating activities, including non-cash stock based compensation, fair value adjustment to contingent consideration, transaction costs, tax receivable agreement liability adjustment, contract termination expense and other non-recurring charges. Adjusted EBITDA does not represent, and should not be considered as, an alternative to net income or cash flows from operations, each as determined in accordance with U.S. GAAP. We have presented adjusted EBITDA because we consider it an important supplemental measure of our performance and believe that it is frequently used by analysts, investors and other interested parties in the evaluation of companies. Other companies may calculate adjusted EBITDA differently than we do. Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under U.S. GAAP.


Reconciliation of Premium Equivalents to Revenues & Adjusted Gross Margin

For the Three months and Year Ended December 31, 2014 and 2013

(Unaudited)

(in thousands)

 

     Three months ended
December 31,
     Year Ended December 31,  
     2014      2013      2014      2013  

Premium equivalents (1)

   $ 45,664       $ 27,746       $ 156,039       $ 100,002   

Less risk premium

     18,189         11,236         63,900         40,922   

Less amounts earned by third party obligors

     945         689         3,381         2,441   
  

 

 

    

 

 

    

 

 

    

 

 

 

Revenues

  26,530      15,821      88,758      56,639   

Cost of revenues

  1,994      —        2,391      —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross margin

  24,536      15,821      86,367      56,639   

Third-party commissions

  12,183      7,806      42,760      32,244   

Credit card and ACH fees

  496      312      1,863      1,173   
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted gross margin (2)

$ 11,857    $ 7,703    $ 41,744    $ 23,222   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) Premium equivalents is defined as the combination of premiums, fees for discount benefit plans, fees for distributors and our enrollment fees. Premium equivalents does not represent, and should not be considered as, an alternative to revenues, as determined in accordance with U.S. GAAP. We have included premium equivalents in this press release because it is a key measure used by our management to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget and to develop short-term and long-term operational plans. In particular, the inclusion of premium equivalents can provide a useful measure for period-to-period comparisons of our business. Premium equivalents has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under U.S. GAAP.
(2) Adjusted gross margin is defined as gross margin less third party commissions and credit card and ACH fees. Adjusted gross margin does not represent, and should not be considered as, an alternative to revenues, as determined in accordance with U.S. GAAP. We have included adjusted gross margin in this press release because it is a key measure used by our management to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget and to develop short-term and long-term operational plans. In particular, the inclusion of adjusted gross margin can provide a useful measure for period-to-period comparisons of our business. Adjusted gross margin has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Adjusted gross margin may not accurately reflect our costs of generating revenues in the periods presented.


Reconciliation of Adjusted EBITDA to Adjusted Net Income per Share

For the Three months and Year Ended December 31, 2014 and 2013

(Unaudited)

(in thousands except per share data)

 

     Three months ended
December 31,
     Year Ended December 31,  
     2014      2013      2014      2013  

Adjusted EBITDA (1)

   $ 2,755       $ 1,799       $ 8,063       $ 5,886   

Less depreciation

     49         24         160         95   
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted pre-tax income

  2,706      1,775      7,903      5,791   

Income tax expense

  1,028      675      3,003      2,201   
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted net income (2)

$ 1,678    $ 1,100    $ 4,900    $ 3,590   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted share count

  14,470      13,638      12,899      13,380   
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted net income per share (3)

$ 0.12    $ 0.08    $ 0.38    $ 0.27   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) Adjusted EBITDA is calculated as set forth above under Reconciliation of Net Income (Loss) to EBITDA and Adjusted EBITDA.
(2) Adjusted net income is computed by subtracting depreciation (but not amortization of intangible assets) from adjusted EBITDA to determine adjusted pre-tax income, from which an assumed tax expense calculated at the 38% federal statutory rate is deducted.
(3) Adjusted net income per share is computed by dividing adjusted net income by the total number of diluted Class A and Class B shares for each period. We have included adjusted net income per share in this press release because it is a key measure used by our management to understand and evaluate our core operating performance and trends and because we believe it is frequently used by analysts, investors and other interested parties in the evaluations of companies. Other companies may calculate this measure differently than we do. Adjusted net income per share has limitations as an analytical tool, and you should not consider it in isolation or substitution for earnings per shares as reported under U.S. GAAP.

CONTACTS:

Health Insurance Innovations, Inc.:

Dirk Montgomery

Chief Financial Officer

(877) 376 5831 ext. 282

dmontgomery@hiiquote.com

Investor Contact:

Susan Noonan

S.A. Noonan Communications, LLC

(212) 966 3650

susan@sanoonan.com


Media Contact for HealthPocket.com:

Emily Cashel

Shirley & Banister Public Affairs

(703) 739 5920/(800) 536 5920

ecashel@sbpublicaffairs.com